49
In band
Moving averages
SMA 200$4.73-24.31%
Company profile
BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
SectorHealthcare
IndustryBiotechnology
Market cap$31.58M
P/E ratioNone
EPS$-0.84
Beta1.532
Dividend yield0.00%
52-week high$14.68
52-week low$2.60
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 44
VRTX
Vertex Pharmaceuticals Inc
RSI 44
CRSP
CRISPR Therapeutics AG
RSI 41
IOVA
Iovance Biotherapeutics Inc
RSI 70
MRNA
Moderna Inc
RSI 60
VKTX
Viking Therapeutics Inc
RSI 34
SRPT
Sarepta Therapeutics Inc
RSI 55
EDIT
Editas Medicine Inc
RSI 43
NVAX
Novavax Inc
RSI 51
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46
RSI alerts for BCTX
Get an email the moment Briacell Therapeutics Corp crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 8:57 AM EDT